GABAPENTIN 300 MG CAPSULE
For 30 capsules
Pharmacies pay
$0.94 filed
30 × $0.03142 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$3.58 filed
30 × $0.1192 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.8× estimated
Medicare paid 3.8× what pharmacies pay.
Part D averages every strength and form sold under “Gabapentin” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.08 estimated
$0.94 + $0.14 (15%) + $5.00 fee per fill = $6.08
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GABAPENTIN 300 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as gabapentin.
FDA gives its dosage form as capsule and its route as oral.
FDA lists 21 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 54 NDCs (National Drug Codes); the FDA directory lists 47 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.94 for 30 capsules (30 × $0.03142 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 21 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Amneal Pharmaceuticals LLC | 3 | $0.03142 per EA filed |
| Ascend Laboratories, LLC | 3 | $0.03142 per EA filed |
| Aurobindo Pharma Limited | 3 | $0.03142 per EA filed |
| Granules Pharmaceuticals Inc | 3 | $0.03142 per EA filed |
| Mullan Pharmaceutical Inc. | 3 | $0.03142 per EA filed |
| Rising Pharma Holdings, Inc. | 3 | $0.03142 per EA filed |
| ScieGen Pharmaceuticals, Inc. | 3 | $0.03142 per EA filed |
| Strides Pharma Science Limited | 3 | $0.03142 per EA filed |
| TIME CAP LABORATORIES, INC | 3 | $0.03142 per EA filed |
| Actavis Pharma, Inc. | 2 | $0.03142 per EA filed |
| Amici Pharma, Inc. | 2 | $0.03142 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.03142 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2 | $0.03142 per EA filed |
| Laurus Labs Limited | 2 | $0.03142 per EA filed |
| NorthStar Rx LLC | 2 | $0.03142 per EA filed |
| Teva Pharmaceuticals, Inc. | 2 | $0.03142 per EA filed |
| Westminster Pharmaceuticals, LLC | 2 | $0.03142 per EA filed |
| American Health Packaging | 1 | $0.03142 per EA filed |
| Cipla USA Inc. | 1 | $0.03142 per EA filed |
| Exelan Pharmaceuticals, Inc. | 1 | $0.03142 per EA filed |
| Major Pharmaceuticals | 1 | $0.03142 per EA filed |
| Not listed as a package in the FDA directory | 7 | $0.03142 per EA filed |
All 54 NDCs, with labeler and price
- 00480-3495-01 · Teva Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 00480-3495-05 · Teva Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 00904-6666-61 · Major Pharmaceuticals · $0.03142 per EA · eff. 2026-09-23 filed
- 16571-0868-01 · Rising Pharma Holdings, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 16571-0868-10 · Rising Pharma Holdings, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 16571-0868-50 · Rising Pharma Holdings, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 16714-0662-01 · NorthStar Rx LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 16714-0662-02 · NorthStar Rx LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 23155-0867-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 23155-0867-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 23155-0867-10 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 31722-0149-01 · Camber Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 31722-0149-05 · Camber Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 42385-0973-01 · Laurus Labs Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 42385-0973-05 · Laurus Labs Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 43547-0266-10 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 45963-0556-11 · Actavis Pharma, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 45963-0556-50 · Actavis Pharma, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 49483-0606-01 · TIME CAP LABORATORIES, INC · $0.03142 per EA · eff. 2026-09-23 filed
- 49483-0606-10 · TIME CAP LABORATORIES, INC · $0.03142 per EA · eff. 2026-09-23 filed
- 49483-0606-50 · TIME CAP LABORATORIES, INC · $0.03142 per EA · eff. 2026-09-23 filed
- 50228-0180-01 · ScieGen Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 50228-0180-05 · ScieGen Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 50228-0180-10 · ScieGen Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 60687-0591-01 · American Health Packaging · $0.03142 per EA · eff. 2026-09-23 filed
- 60687-0591-11 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 64380-0754-01 · Strides Pharma Science Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 64380-0754-02 · Strides Pharma Science Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 64380-0754-03 · Strides Pharma Science Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 65162-0102-10 · Amneal Pharmaceuticals LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 65162-0102-11 · Amneal Pharmaceuticals LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 65162-0102-50 · Amneal Pharmaceuticals LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 65862-0199-01 · Aurobindo Pharma Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 65862-0199-05 · Aurobindo Pharma Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 65862-0199-99 · Aurobindo Pharma Limited · $0.03142 per EA · eff. 2026-09-23 filed
- 67877-0223-01 · Ascend Laboratories, LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 67877-0223-05 · Ascend Laboratories, LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 67877-0223-10 · Ascend Laboratories, LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 69097-0943-12 · Cipla USA Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 69292-0641-01 · Amici Pharma, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 69292-0641-50 · Amici Pharma, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 69367-0132-06 · Westminster Pharmaceuticals, LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 69367-0344-05 · Westminster Pharmaceuticals, LLC · $0.03142 per EA · eff. 2026-09-23 filed
- 70010-0927-01 · Granules Pharmaceuticals Inc · $0.03142 per EA · eff. 2026-09-23 filed
- 70010-0927-05 · Granules Pharmaceuticals Inc · $0.03142 per EA · eff. 2026-09-23 filed
- 70010-0927-10 · Granules Pharmaceuticals Inc · $0.03142 per EA · eff. 2026-09-23 filed
- 71093-0121-04 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 71093-0121-05 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 71093-0162-04 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 71093-0162-05 · not listed as a package in the FDA directory · $0.03142 per EA · eff. 2026-09-23 filed
- 76282-0627-05 · Exelan Pharmaceuticals, Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 83301-0004-01 · Mullan Pharmaceutical Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 83301-0004-02 · Mullan Pharmaceutical Inc. · $0.03142 per EA · eff. 2026-09-23 filed
- 83301-0004-03 · Mullan Pharmaceutical Inc. · $0.03142 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
20 other products in the NADAC file share the FDA nonproprietary name gabapentin with GABAPENTIN 300 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GABAPENTIN 100 MG CAPSULE | $0.02184 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 250 MG/5 ML SOLN | $0.08761 to $0.1712 per ML filed | We don’t know yet |
| GABAPENTIN 300 MG CAPSULE this page | $0.03142 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 400 MG CAPSULE | $0.04222 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 600 MG TABLET | $0.06398 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 800 MG TABLET | $0.08829 per EA filed | $0.1192 per EA filed |
| GABAPENTIN ER 300 MG TABLET | $0.63846 per EA filed | $5.0138 per EA filed |
| GABAPENTIN ER 600 MG TABLET | $1.02497 per EA filed | $5.0138 per EA filed |
| GABARONE 100 MG TABLET | $8.78889 per EA filed | We don’t know yet |
| GABARONE 400 MG TABLET | $8.57111 per EA filed | We don’t know yet |
| GRALISE ER 300 MG TABLET | $10.18511 per EA filed | We don’t know yet |
| GRALISE ER 450 MG TABLET | $10.14274 per EA filed | We don’t know yet |
| GRALISE ER 600 MG TABLET | $10.15306 per EA filed | We don’t know yet |
| GRALISE ER 900 MG TABLET | $15.20748 per EA filed | We don’t know yet |
| NEURONTIN 100 MG CAPSULE | $2.95761 per EA filed | $8.87549 per EA filed |
| NEURONTIN 300 MG CAPSULE | $7.37105 per EA filed | $8.87549 per EA filed |
| NEURONTIN 400 MG CAPSULE | $8.86718 per EA filed | $8.87549 per EA filed |
| NEURONTIN 600 MG TABLET | $14.11861 per EA filed | $8.87549 per EA filed |
| NEURONTIN 800 MG TABLET | $16.88137 per EA filed | $8.87549 per EA filed |
| RELGAABI 300 MG CAPSULE | $0.03142 per EA filed | $0.1192 per EA filed |
| RELGAABI 400 MG CAPSULE | $0.04222 per EA filed | $0.1192 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $3.58 for 30 capsules, at an average of $0.1192 per EA in 2024 (2024-01-01 to 2024-12-31) for “Gabapentin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 36,804,628 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for GABAPENTIN 300 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Gabapentin / Gabapentin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 254 of 262 NADAC NDCs joined to this name are priced per EA (8 per ML): CMS's average mixes those units.